Latest Insider Transactions at Invivo Therapeutics Holdings Corp. (NVIV)
This section provides a real-time view of insider transactions for Invivo Therapeutics Holdings Corp. (NVIV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INVIVO THERAPEUTICS HOLDINGS CORP. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INVIVO THERAPEUTICS HOLDINGS CORP.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2023
|
Brice Foose > 10% Shareholder |
SELL
Open market or private purchase
|
Direct |
164,000
-39.31%
|
$0
$0.43 P/Share
|
|
Feb 05
2023
|
Brice Foose > 10% Shareholder |
SELL
Open market or private purchase
|
Direct |
166,000
-10.82%
|
$0
$0.29 P/Share
|
|
Dec 21
2021
|
Richard M. Toselli CEO and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
16
-0.26%
|
$0
$0.54 P/Share
|
|
Jun 21
2021
|
Richard M. Toselli CEO and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
21
-0.34%
|
$0
$0.74 P/Share
|
|
Dec 21
2020
|
Richard M. Toselli CEO and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
16
-0.26%
|
$0
$0.6 P/Share
|